Earnings History Data for Nephros, Inc. (NEPH) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nephros, Inc.
Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | NEPH | Nephros, Inc. | 15.82 | 0.02 | 0.00 | -0.02 | Nephros reports Q3 results [11/8/2024 4:52 AM] |
1.62 | 0.07 (4.84%) |
1.56 | 0.01 (0.65%) |
1.36 - 4.04 | 10,206 | 10,000 | 4,687 | ||
| 08-08-2024 | PM | NEPH | Nephros, Inc. | 22.99 | -0.03 | 0.00 | -0.04 | Nephros GAAP EPS of -$0.03, revenue of $3.3M [8/9/2024 8:20 AM] |
1.93 | -0.20 (-9.57%) |
2.00 | -0.13 (-6.32%) |
1.35 - 4.04 | 72,929 | 10,000 | 13,300 | ||
| 07-03-2024 | AH | NEPH | Nephros, Inc. | 31.56 | -0.06 | 0.00 | 0.00 | Nephros reports Q4 results [3/7/2024 4:28 PM] |
2.71 | -0.31 (-10.26%) |
2.93 | -0.09 (-2.98%) |
0.95 - 4.04 | 38,404 | 20,000 | 100 | ||
| 08-11-2023 | AH | NEPH | Nephros, Inc. | 17.61 | -0.02 | 0.00 | -0.12 | Nephros GAAP EPS of -$0.02 beats by $0.05, revenue of $3.74M beats by $0.37M [11/8/2023 5:42 PM] |
1.96 | -0.05 (-2.59%) |
0.0 | 0.0 (0.00%) |
0.95 - 2.50 | 1,138 | 10,000 | 0 | ||
| 09-08-2023 | AH | NEPH | Nephros, Inc. | 14.57 | -0.04 | 0.00 | -0.12 | Nephros GAAP EPS of -$0.04 beats by $0.02, revenue of $3.5M beats by $0.4M [8/9/2023 4:39 PM] |
1.47 | 0.07 (5.01%) |
1.41 | 0.01 (0.71%) |
0.91 - 2.50 | 58,425 | 0 | 182 | ||
| 10-05-2023 | AH | 4:15 PM ET (May 10) |
NEPH | Nephros, Inc. | 15.62 | -0.03 | 0.00 | -0.20 | Nephros GAAP EPS of -$0.03 misses by $0.01, revenue of $3.7M beats by $0.02M [5/10/2023 4:39 PM] |
1.41 | -0.05 (-3.42%) |
0.0 | 0.0 (0.00%) |
0.91 - 2.44 | 6,939 | 10,000 | 0 | |
| 08-03-2023 | AH | 4:15 PM ET (Mar 8) |
NEPH | Nephros, Inc. | 11.86 | N/A | 0.00 | -0.11 | Nephros reports Q4 results [3/8/2023 4:30 PM] |
1.01 | -0.12 (-10.61%) |
0.97 | -0.16 (-14.15%) |
0.91 - 5.00 | 52,828 | 10,000 | 5,036 | |
| 02-11-2022 | AH | 4:15 PM ET (Nov 2) |
NEPH | Nephros, Inc. | 10.83 | -0.12 | -0.12 | -0.12 | Nephros GAAP EPS of -$0.31 misses by $0.20, revenue of $2.41M misses by $0.11M [11/2/2022 5:12 PM] |
1.08 | 0.07 (6.90%) |
0.0 | 0.0 (0.00%) |
0.91 - 8.15 | 5,305 | 10,000 | 0 | |
| 10-08-2022 | AH | 4:15 PM ET (Aug 10) |
NEPH | Nephros, Inc. | 15.48 | -0.12 | -0.14 | -0.12 | Nephros GAAP EPS of -$0.12 beats by $0.02, revenue of $2.8M misses by $0.08M [8/10/2022 4:50 PM] |
1.66 | -0.11 (-6.48%) |
1.84 | 0.07 (3.66%) |
1.42 - 9.10 | 21,914 | 20,000 | 2,012 | |
| 04-05-2022 | AH | 4:15 PM ET (May 4) |
NEPH | Nephros | 41.00 | -0.20 | -0.13 | 0.00 | Nephros GAAP EPS of -$0.20 misses by $0.09, revenue of $2.18M misses by $0.92M [5/4/2022 5:10 PM] |
2.53 | -1.72 (-40.47%) |
3.00 | -1.25 (-29.41%) |
2.48 - 11.67 | 265,504 | 34,749 | 16,861 | |
| 23-02-2022 | AH | 4:15 PM ET (Feb 23) |
NEPH | Nephros, Inc. | 46.25 | -0.11 | -0.10 | -0.08 | Nephros reports Q4 results [2/23/2022 4:49 PM] |
4.36 | 0.01 (0.23%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 2,699 | 0 | 0 | |
| 04-11-2021 | AH | 4:15 PM ET (Nov 4) |
NEPH | Nephros, Inc. | 68.70 | -0.12 | -0.12 | -0.12 | Nephros EPS misses by $0.01, revenue in-line [11/4/2021 4:34 PM] |
7.89 | 0.24 (3.14%) |
7.60 | -0.05 (-0.65%) |
5.69 - 11.67 | 9,307 | 0 | 325 | |
| 05-08-2021 | AH | 4:15 PM ET (Aug 5) |
NEPH | Nephros, Inc. | 79.55 | -0.12 | -0.12 | -0.19 | Nephros EPS misses by $0.01, beats on revenue [8/5/2021 5:06 PM] |
7.95 | -0.48 (-5.69%) |
0.0 | 0.0 (0.00%) |
5.08 - 11.67 | 14,930 | 10,000 | 0 | |
| 06-05-2021 | AH | 4:15 PM ET (May 6) |
NEPH | Nephros, Inc. | 71.41 | -0.06 | -0.14 | -0.13 | Nephros EPS beats by $0.05, beats on revenue [5/6/2021 4:32 PM] |
7.37 | -0.40 (-5.15%) |
0.0 | 0.0 (0.00%) |
5.08 - 9.30 | 47,030 | 10,000 | 0 | |
| 01-03-2021 | AH | 4:25 PM ET (Mar 1) |
NEPH | Nephros, Inc. | 69.33 | -0.08 | -0.12 | -0.02 | Nephros beats on revenue [3/1/2021 4:24 PM] |
8.45 | 0.26 (3.17%) |
0.0 | 0.0 (0.00%) |
4.42 - 10.00 | 3,266 | 11,987 | 0 | |
| 05-11-2020 | AH | 4:15 PM ET (Nov 5) |
NEPH | Nephros, Inc. | 58.76 | -0.12 | -0.16 | -0.10 | Nephros EPS beats by $0.02, misses on revenue [11/5/2020 6:03 PM] |
6.02 | -0.22 (-3.53%) |
0.0 | 0.0 (0.00%) |
4.42 - 10.80 | 2,847 | 7,103 | 0 | |
|
|
||||||||||||||||||
| 05-08-2020 | AH | 4:15 PM ET (Aug 5) |
NEPH | Nephros, Inc. | 73.23 | -0.19 | -0.12 | -0.14 | Nephros EPS misses by $0.04, misses on revenue [8/5/2020 4:30 PM] |
8.28 | 0.02 (0.24%) |
0.0 | 0.0 (0.00%) |
4.42 - 11.35 | 2,256 | 10,316 | 0 | |
|
|
||||||||||||||||||
| 06-05-2020 | AH | NEPH | Nephros, Inc. | 73.03 | -0.13 | -0.12 | -0.18 | 0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |||
|
|
||||||||||||||||||